Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

The journal welcomes submissions in all of these fields.

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies

Journal information

Coordinating Editor
  • Trevor W. Robbins,
  • Christelle Baunez,
  • Patricia H. Janak
Principal Editor
  • Harriet de Wit,
  • Valerie H Curran,
  • A. Leslie Morrow,
  • Kenji Hashimoto,
  • Oliver Howes,
  • Stan B. Floresco,
  • Deepak D'Souza
Publishing model
Hybrid (Transformative Journal). Learn about publishing Open Access with us

Journal metrics

4.530 (2020)
Impact factor
4.076 (2020)
Five year impact factor
59 days
Submission to first decision
159 days
Submission to acceptance
1,073,694 (2020)
Downloads

Latest articles

Journal updates

  • COVID-19 and impact on peer review

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

  • Call for papers for a Special Issue on “Psychopharmacology on Psychedelic Drugs”

    We are pleased to announce an upcoming Special Issue of Psychopharmacology on Psychedelic Drugs. 

    We are excited to invite you to contribute to a special issue of Psychopharmacology on Psychedelics.  We welcome both review articles and empirical papers, including submissions from all types of research including mechanisms, brain imaging, immune function, therapeutic potential, cognition, abuse liability and regulatory issues.  

View all updates

Subscribe

eJournal
$119.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles starting 1997
  • Downloadable in PDF format
  • Subscription expires 12/31/2021

About this journal

Electronic ISSN
1432-2072
Print ISSN
0033-3158
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Biological Abstracts
  5. CAB Abstracts
  6. CNKI
  7. Chemical Abstracts Service (CAS)
  8. Current Contents/ Life Sciences
  9. Dimensions
  10. EBSCO Academic Search
  11. EBSCO Advanced Placement Source
  12. EBSCO Biomedical Reference Collection
  13. EBSCO CINAHL
  14. EBSCO Discovery Service
  15. EBSCO Psychology & Behavioral Sciences Collection
  16. EBSCO Rehabilitation & Sports Medicine Source
  17. EBSCO SPORTDiscus
  18. EBSCO STM Source
  19. EMBASE
  20. ERIH PLUS
  21. Gale
  22. Google Scholar
  23. IFIS Publishing
  24. Japanese Science and Technology Agency (JST)
  25. Journal Citation Reports/Science Edition
  26. Medline
  27. Meta
  28. Naver
  29. Norwegian Register for Scientific Journals and Series
  30. OCLC WorldCat Discovery Service
  31. Pathway Studio
  32. ProQuest Agricultural & Environmental Science Database
  33. ProQuest Animal Behavior Abstracts
  34. ProQuest Biological Science Database
  35. ProQuest Central
  36. ProQuest Chemoreception Abstracts
  37. ProQuest Environmental Science
  38. ProQuest Health & Medical Collection
  39. ProQuest Health Research Premium Collection
  40. ProQuest Medical Database
  41. ProQuest Natural Science Collection
  42. ProQuest Neurosciences Abstracts
  43. ProQuest Nursing & Allied Health Database
  44. ProQuest Pharma Collection
  45. ProQuest Psychology Database
  46. ProQuest SciTech Premium Collection
  47. ProQuest Toxicology Abstracts
  48. ProQuest-ExLibris Primo
  49. ProQuest-ExLibris Summon
  50. PsycINFO
  51. Reaxys
  52. SCImago
  53. SCOPUS
  54. Science Citation Index
  55. Science Citation Index Expanded (SciSearch)
  56. TD Net Discovery Service
  57. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer-Verlag GmbH Germany, part of Springer Nature